Cargando…
Combating pancreatic cancer with ovarian cancer cells
With overall five-year survival rate less than 10%, pancreatic cancer (PC) represents the most lethal one in all human cancers. Given that the incidence of PC is still increasing and current cancer treatment strategies are often inefficacious, its therapy is still a huge challenge. Here, we first re...
Autores principales: | Lin, Xiao, Cui, Chunmei, Cui, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085619/ https://www.ncbi.nlm.nih.gov/pubmed/36961421 http://dx.doi.org/10.18632/aging.204608 |
Ejemplares similares
-
Targeting tumor-associated macrophages to combat pancreatic cancer
por: Cui, Ran, et al.
Publicado: (2016) -
B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells
por: Li, Dongbao, et al.
Publicado: (2017) -
Depleting ovarian cancer stem cells with calcitriol
por: Srivastava, Amit Kumar, et al.
Publicado: (2018) -
TAMing pancreatic cancer: combat with a double edged sword
por: Lankadasari, Manendra Babu, et al.
Publicado: (2019) -
MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2017)